Emily Roarty Selected Research

Nucleotides

1/2019

Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emily Roarty Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 01/2018
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2018
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 01/2018
2	Lung Neoplasms (Lung Cancer) 12/2018 - 01/2018
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Carcinogenesis 01/2019

Drug/Important Bio-Agent (IBA)

2	Circulating Tumor DNAIBA 01/2019 - 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	NucleotidesIBA 01/2019
1	osimertinibIBA 12/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2018